Inventor · disambiguated record
Daniel P. Gold
Also filed as: GOLD DANIEL · GOLD DANIEL P
10 granted patents·18 pending applications·55 citations·filing 1993–2023
86Inventor score
Top patents by PatentIndex Score
28 records- 0188US11351176B2Combination therapyMEI PHARMA INC·Filed 2018·Granted Jun 7, 2022·4 cites·19 claims
- 0288US11304953B2Combination therapyMEI PHARMA INC·Filed 2018·Granted Apr 19, 2022·4 cites·19 claims
- 0379US10980774B2Combination therapiesMEI PHARMA INC·Filed 2016·Granted Apr 20, 2021·2 cites·6 claims
- 0477US6911204B2Method and composition for altering a B cell mediated pathologyFAVRILLE INC·Filed 2001·Granted Jun 28, 2005·9 cites·21 claims
- 0572US12161644B2Combination therapyMEI PHARMA INC·Filed 2022·Granted Dec 10, 2024·0 cites·15 claims
- 0670US8114404B2Method and composition for altering a B cell mediated pathologyGOLD DANIEL P·Filed 2004·Granted Feb 14, 2012·2 cites·44 claims
- 0769US8637638B2Method and composition for altering a B cell mediated pathologyGOLD DANIEL P·Filed 2011·Granted Jan 28, 2014·1 cites·18 claims
- 0868US2014322160A1Method and composition for altering a b cell mediated pathologyMMRGLOBAL INC·Filed 2013·Application pending·0 cites
- 0967US6464978B1Vaccination and methods against multiple sclerosis resulting from pathogenic responses by specific T cell populationsIMMUNE RESPONSE CORP INC·Filed 1993·Granted Oct 15, 2002·33 cites·23 claims
- 1067US2022265673A1Combination therapyMEI PHARMA INC·Filed 2022·Application pending·0 cites
- 1162US2025177409A1Combination therapy of pi3k inhibitor and pd-1 inhibitorMEI PHARMA INC·Filed 2023·Application pending·0 cites
- 1261US12414934B2Combination therapiesAARDVARK THERAPEUTICS INC·Filed 2021·Granted Sep 16, 2025·0 cites·13 claims
- 1360US2021100775A1Combination therapiesMEI PHARMA INC·Filed 2020·Application pending·0 cites
- 1457US2024197680A1Voruciclib dosing regimens and methods of treatment including the sameMEI PHARMA INC·Filed 2022·Application pending·0 cites
- 1556US8133486B2Method and composition for altering a B cell mediated pathologyGOLD DANIEL P·Filed 2004·Granted Mar 13, 2012·0 cites·13 claims
- 1655US2023233519A1Combination therapiesMEI PHARMA INC·Filed 2021·Application pending·0 cites
- 1755US2024016781A1Treatment of kras mutant cancersMEI PHARMA INC·Filed 2021·Application pending·0 cites
- 1855US2005084495A1Altering A B cell pathology using self-derived antigens in conjunction with specific-binding cytoreductive agentFAVRILLE INC·Filed 2004·Application pending·0 cites
- 1952US2021196725A1Treatment of relapsed follicular lymphomaMEI PHARMA INC·Filed 2019·Application pending·0 cites
- 2052US2021161909A1Combination therapyMEI PHARMA INC·Filed 2019·Application pending·0 cites
- 2150US2021000838A1Combination therapyMEI PHARMA INC·Filed 2019·Application pending·0 cites
- 2249US2015258068A1Combination therapiesMEI PHARMA INC·Filed 2013·Application pending·0 cites
- 2345US2016082113A1Altering a b cell pathology using self-derived antigens in conjunction with specific-binding cytoreductive agentMMRGLOBAL INC·Filed 2015·Application pending·0 cites
- 2445US2021299134A1Treatment of b cell malignanciesMEI PHARMA INC·Filed 2019·Application pending·0 cites
- 2545US2019201409A1Combination therapyMEI PHARMA INC·Filed 2017·Application pending·0 cites
- 2640US2002006413A1Genetically engineered tumor cell vaccinesFiled 2001·Application pending·0 cites
- 2738US2003012782A1Method and composition for altering a T cell mediated pathologyFiled 2001·Application pending·0 cites
- 2830US2012251630A1Remission therapy of cancer with isoflavonoidsALVERO AYESHA B·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Daniel P. Gold files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →